AR and prostate carcinoma: As a part of our studies of androgen receptor (AR) function and mechanisms of CRPC progression, we recently characterized four new murine prostate cancer cell lines derived from either hormone intact (E4, E8) or castrated (cE1, cE2) Pten null mutant mice.